google-site-verification: googlec7193c3de77668c9.html
Wednesday , November 4 2026

FDA provides breakthrough device designation to MeMed BV Flex

[
The U.S. Food and Drug Administration has granted Breakthrough Device designation to MeMed BV Flex, a blood test that differentiates between bacterial and viral infections.


Source link

Advertisements

See also  Bacteria 'leaking across stomach lining' could indicate risk of gastric cancer, study finds

Check Also

How a gut virus hijacks mucus production to slip past the body's protective barrier

[ Among the various viruses that sicken your gut, some at least leave behind a …

Large unexplained variation in emergency care hospital admission rates in England

[ Neither local case mix, primary care provision nor geography explains the large differences in …

‘Multi-cancer’ blood tests coming to some GP surgeries

The government-funded trial, led by the University of Birmingham, will assess whether the tests are …

Leave a Reply

Available for Amazon Prime